We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > 2023

News List

Global top 20 Best-Selling Race of Medicine by 2023 Shruti Talashi
September 26, 2024
Top 20 medications by global sales list of 2023 was not without its surprises, given the year's significant patent expirations, the emergence of weight-loss medications, and other novel developments.
Promentis Announces Successful Completion of SXC-2023 Studies americanpharmaceuticalreview
November 20, 2018
Promentis Pharmaceuticals has completed Phase 1 single ascending dose and multiple ascending dose studies for its lead c
AstraZeneca gets back to growth, but can it hit $40B by 2023? CEO says yes—again biospectrum
November 12, 2018
AstraZeneca CEO Pascal Soriot has repeatedly said his company would finally get back on the upswing in the second half of this year, and he’s put skeptics to rest with strong third-quarter numbers.
Forget Tagrisso's $3B sales target. It'll be worth double that by 2023, analyst says fiercepharma
June 26, 2018
Recent approvals of Tagrisso in the first-line lung cancer setting have AstraZeneca management optimistic about the $3 billion sales target it set several years ago. But some analysts have higher hopes—and one just came up with a bullish estimate that's o